Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Open-market sale 10% owner sold 425,000 shares at an average $30.82 ($13,098,000)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale Director sold 750,000 shares at $28.25 ($21,188,325)
  5. 4 Other disposition FMR LLC disposed of 639,627 shares (other)
  6. 4 Shares withheld for taxes Chief Operating Officer gave up 494 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Financial Officer gave up 380 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Legal Officer gave up 327 shares (to pay taxes)
  9. 4 Shares withheld for taxes President and CEO gave up 889 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Scientific Officer gave up 441 shares (to pay taxes)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale 10% owner sold 907,828 shares at an average $23.03 ($20,908,049)
  17. 4 Open-market sale Chief Legal Officer sold 3,912 shares at $21.83 ($85,399)
  18. 4 Open-market sale 10% owner sold 3,750 shares at an average $21.94 ($82,260)
  19. 4 Other disposition 10% owner disposed of 84,223 shares (other)
  20. 4 Open-market sale Chief Legal Officer sold 1,841 shares at $24.66 ($45,399)

Page 18 of 21 · 414 filings